Short- and long-term evaluation of disease-specific symptoms and quality of life following uterine artery embolization of fibroids

Insights into Imaging

Table 2 Changes in symptom severity and HRQoL scores after long-term follow-up (n = 59)

UFS-QoL subscale	n¹	Before UAE Median (25. 75.P)	Long-term follow-up Median (25. 75.P)	p value (Wilcoxon test)
Symptom severity	56	50.0 (34.4 62.5)	9.4 (0.0 24.2)	< 0.001
Concern	55	55.0 (35.0 80.0)	100.0 (80.0 100.0)	< 0.001
Activities	57	46.4 (28.6 57.1)	100.0 (82.1 100.0)	< 0.001
Energy/mood	57	46.4 (30.4 71.4)	100.0 (78.6 100.0)	< 0.001
Control	58	50.0 (30.0 71.2)	100.0 (80.0 100.0)	< 0.001
Self-consciousness	58	58.3 (33.3 85.4)	100.0 (75.0 100.0)	< 0.001
Sexual function	55	37.5 (25.0 75.0)	100.0 (75.0 100.0)	< 0.001
HRQoL total score	51	49.1 (38.8 60.3)	95.3 (81.0 100.0)	< 0.001

(1) n = Number of patients with sufficient answered questions for the calculation of transformed scores using the ‘UFS-QoL Scoring Manual’